Biogen’s Alzheimer’s disease treatment is FDA approved

Saying that the benefits outweighed the risks, the Food and Drug Administration approved Biogen’s aducanumab on Monday. (BIIB) – Get report long-awaited drug for Alzheimer’s disease.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top